{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:21:08Z","timestamp":1791541268879,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116054","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:27:48Z","timestamp":1708118868000},"page":"116054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Validation and application of a method for the quantification of 137 drugs of abuse and new psychoactive substances in hair"],"prefix":"10.1016","volume":"243","author":[{"given":"Rossella","family":"Barone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Pelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Paola","family":"Pascali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sablone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Introna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susi","family":"Pelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116054_bib1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), New psychoactive substances \u2013 the current situation in Europe (European Drug Report 2023). \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023\/new-psychoactive-substances_en\u3009, 2023 (Accessed 12 October 2023)."},{"key":"10.1016\/j.jpba.2024.116054_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/dta.2786","article-title":"Impact of legislation on NPS markets in Germany - the rise and fall of 5F-ADB","volume":"12","author":"Halter","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1373\/clinchem.2017.274662","article-title":"Impact of novel psychoactive substances on clinical and forensic toxicology and global public health","volume":"63","author":"Huestis","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2024.116054_bib4","first-page":"440","article-title":"Molecular mechanisms of action of novel psychoactive substances (NPS). A new threat for young drug users with forensic-toxicological implications","volume":"11","author":"Giorgetti","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jpba.2024.116054_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jat\/bkz030","article-title":"HighResNPS.com: an online crowd-sourced hr-ms database for suspect and non-targeted screening of new psychoactive substances","volume":"43","author":"Mardal","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116054_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/dta.2535","article-title":"Development of a sensitive untargeted liquid chromatography-high resolution mass spectrometry screening devoted to hair analysis through a shared MS2 spectra database: A step toward early detection of new psychoactive substances","volume":"11","author":"Fabresse","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib7","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00204-016-1764-1","article-title":"High-resolution mass spectrometry in toxicology: current status and future perspectives","volume":"90","author":"Maurer","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2024.116054_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/dta.3170","article-title":"Development and validation of a rapid LC-MS\/MS method for the detection of 182 novel psychoactive substances in whole blood","volume":"14","author":"Giorgetti","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.aca.2016.04.046","article-title":"Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?","volume":"927","author":"Meyer","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116054_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fpsyt.2020.00569","article-title":"Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment","volume":"11","author":"Specka","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2024.116054_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.011","article-title":"Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017)","volume":"204","author":"Larabi","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2024.116054_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015716","article-title":"Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions","volume":"7","author":"Bennett","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpba.2024.116054_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.956120","article-title":"Synthetic cannabinoids use in a sample of opioid-use disorder patients","volume":"13","author":"Al\u00edas -Ferri","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2024.116054_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hup.2512","article-title":"New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening","volume":"31","author":"Heikman","year":"2016","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.116054_bib15","doi-asserted-by":"crossref","first-page":"14619","DOI":"10.3390\/ijms232314619","article-title":"Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances","volume":"23","author":"Di Trana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.116054_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/dta.1610","article-title":"New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?","volume":"6","author":"Gin\u00e9","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib17","first-page":"5480","article-title":"Hair analysis in forensic toxicology: an updated review with a special focus on pitfalls","volume":"23","author":"Kintz","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2024.116054_bib18","unstructured":"Society of Hair Testing (SoHT), Consensus on general recommendations for hair testing. \u3008https:\/\/www.soht.org\/images\/pdf\/General_Consensus_Hair_Testing_2022.pdf\u3009), 2022 (accessed 30 January 2023)."},{"key":"10.1016\/j.jpba.2024.116054_bib19","first-page":"4","article-title":"Interpretation of NPS results in real hair samples","volume":"29","author":"Salomone","year":"2017","journal-title":"Toxicol. Anal. Et. Clin."},{"key":"10.1016\/j.jpba.2024.116054_bib20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.toxrep.2021.09.003","article-title":"Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?","volume":"8","author":"Florou","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jpba.2024.116054_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jat\/bkx020","article-title":"Hair testing for drugs of abuse and new psychoactive substances in a high-risk population","volume":"41","author":"Salomone","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116054_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/dta.1338","article-title":"Prevalence of new psychoactive substances: A retrospective study in hair","volume":"4","author":"Rust","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib23","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1007\/s00216-020-02462-6","article-title":"Development and validation of fast UHPLC-MS\/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases","author":"Mannocchi","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116054_bib24","unstructured":"European Medicine Agency, ICH-M10 Bionalytical method validation scientific guidelines \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf\u3009, (accessed 16 October 2023)."},{"key":"10.1016\/j.jpba.2024.116054_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.talanta.2017.05.049","article-title":"Some practical considerations for linearity assessment of calibration curves as function of concentration levels according to the fitness-for-purpose approach","volume":"172","author":"Jurado","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116054_bib26","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116054_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109914","article-title":"Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy","volume":"302","author":"Pelletti","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116054_bib28","series-title":"Perspectives and Challenges of Hair Analysis","article-title":"Chapter 4: Insight into drug extraction from the keratin matrix","author":"Jurado","year":"2023"},{"key":"10.1016\/j.jpba.2024.116054_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110337","article-title":"A different insight in hair analysis: simultaneous measurement of antipsychotic drugs and metabolites in the protein and melanin fraction of hair from criminal justice patients","volume":"312","author":"Ram\u00edrez Fern\u00e1ndez","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116054_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.forsciint.2017.08.031","article-title":"The analysis of 132 novel psychoactive substances in human hair using a single step extraction by tandem LC\/MS","volume":"279","author":"Boumba","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116054_bib31","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00216-015-9247-4","article-title":"Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples","volume":"408","author":"Salomone","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116054_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/dta.3150","article-title":"Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: a 13-year retrospective study","volume":"14","author":"Niebel","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/dta.1556","article-title":"Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers","volume":"6","author":"Salomone","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116054_bib34","unstructured":"Society of Hair Testing (SoHT), Consensus on drugs of abuse (DOA) testing in hair. \u3008https:\/\/www.soht.org\/images\/pdf\/Consensus_DoA_2021.pdf\u3009, 2021 (accessed 16 October 2023)."},{"key":"10.1016\/j.jpba.2024.116054_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jat\/bkad040","article-title":"Are the NPS commonly used? An extensive investigation in Northern Italy based on hair analysis","volume":"47","author":"Calvetti","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116054_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drugalcdep.2014.05.001","article-title":"Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use","volume":"141","author":"Gryczynski","year":"2014","journal-title":"Drug Alcohol Depend."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:04:22Z","timestamp":1715270662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S0731708524000943"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116054","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and application of a method for the quantification of 137 drugs of abuse and new psychoactive substances in hair","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116054"}}